Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Cohort Study With Chart Review to Assess the Management of Major Bleeding Events in NVAF Patients Treated With Dabigatran Etexilate

NCT02149303 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02149303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02149303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Cohort Study With Chart Review to Assess the Management of Major Bleeding Events in NVAF Patients Treated With Dabigatran Etexilate
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
March 31, 2015
Enrollment
191 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, hemorrhage